Skip to main content
CRITERIA strengthening the network to generate knowledge and skills on explicit prioritization and benefit plans in Latin America
There is a growing need to prioritize public spending on health in Latin America and the Caribbean, especially in the context of universal health coverage, as is amply demonstrated that no economy in the world can pay all health technologies available to cover health needs of all citizens. This situation is worse, because although health spending has grown significantly in recent years (an analysis of per capita spending between 2000 and 2013 indicates that this has risen from around 500 US $ in 2000 (PPP constant 2011) , to about 4,500 in 2013 (World Development Indicators, 2015)), this is in the region on average five times less (US $ 761; 2013) than in high-income countries (US $ 4,652; 2013) (World Bank, 2014) , despite health needs they are similar.
There are many pressures on health spending fruit, among others, the change in the epidemiological and demographic profile of the region. However, the factor that has pushed spending growth has been the emergence and use of increasingly expensive health technologies. According to a recent review of international literature, technological pressure on average account for 50% of growth of health spending (Sorenson, et al.2013).
About this, it is important to note that the countries of the region face strong pressure from different stakeholders (patients, doctors, producers and distributors of health technologies) for new technologies with public resources are covered. These factors combine to explain why several countries in the region have seen rapidly grow your drug expenses and why Latin America is an increasingly important part of the world pharmaceutical market. To illustrate the importance of the region in this market, according to the Global Health Intelligence (2015), the growth of Latin American drug market by 2017 will be 12%, an increase four times higher than report the European market and the US.

Project Detail

Country

Regional

Project Number

RG-T2680

Approval Date

April 28, 2016

Project Status

Closed

Project Type

Technical Cooperation

Sector

HEALTH

Subsector

HEALTH SYSTEM STRENGTHENING

Lending Instrument

-

Lending Instrument Code

-

Modality

-

Facility Type

-

Environmental Classification

-

Total Cost

USD 200,000.00

Country Counterpart Financing

USD 0.00

Original Amount Approved

USD 200,000.00

Financial Information
Operation Number Lending Type Reporting Currency Reporting Date Signed Date Fund Financial Instrument
ATN/OC-15553-RG Sovereign Guaranteed USD - United States Dollar Ordinary Capital Nonreimbursable
Operation Number ATN/OC-15553-RG
  • Lending Type: Sovereign Guaranteed
  • Reporting Currency: USD - United States Dollar
  • Reporting Date:
  • Signed Date:
  • Fund: Ordinary Capital
  • Financial Instrument: Nonreimbursable

Can’t find a document? Request information

Implementation Phase
https://www.iadb.org/document.cfm?id=EZSHARE-1263968802-12
Approved TC document
Fortalecimiento de la red CRITERIA para generarconocimiento y capacidades sobre priorizaciónexplícita y planes d [40269936].PDF
May. 05, 2016
Spanish
Other Documents
https://www.iadb.org/document.cfm?id=EZSHARE-631120200-2
TC Abstract
Fortalecimiento Red CRITERIA para priorización y planes de beneficios en AL [39702963].PDF
Jun. 29, 2015
Spanish
https://www.iadb.org/document.cfm?id=EZSHARE-1263968802-11
TC Abstract
Filtros Ambientales [39698694].PDF
Aug. 03, 2015
English
https://www.iadb.org/document.cfm?id=EZSHARE-1691535712-17
Technical Note
El-efecto-portafolio-de-la-regulacion-de-precios-de-medicamentos.pdf
Sep. 05, 2018
Spanish
https://www.iadb.org/document.cfm?id=EZSHARE-1691535712-8
Access to Information
La-priorizacion-en-salud-paso-a-paso-comoarticulan-sus-procesos-mexico-brasil-y-colombia_VERSION FINAL CONVERGENCE.pdf
Apr. 30, 2018
Spanish

Have an Environmental or Social issue related to IDB projects? File a Complaint

Jump back to top